Literature DB >> 33539174

Catalyzing Childhood Cancer Care in Peru After One Year of the Global Initiative for Childhood Cancer.

Liliana Vasquez1, Essy Maradiegue2, Ninoska Rojas3, Jacqueline Montoya2, Arturo Zapata2, Cecilia Ugaz2, Claudia Pascual4, Carlos Santillán5, Antonio Wachtel6, Edinho Celis7, Hernan Bernedo8, Jonathan Rossi9, Lily Saldaña10, Rosdali Diaz2, Roxana Morales2, Vivian Perez1, Monika L Metzger11, Silvana Luciani12.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33539174      PMCID: PMC8081553          DOI: 10.1200/GO.20.00601

Source DB:  PubMed          Journal:  JCO Glob Oncol        ISSN: 2687-8941


× No keyword cloud information.
The burden of childhood illnesses has dramatically shifted from communicable to noncommunicable diseases in Peru, with a total estimated population of 32.5 million inhabitants, where cancer is estimated to develop in at least 1800 children and adolescents (0-19 years of age) each year.[1] Up to 70% will present with advanced disease, often metastatic, due to delayed diagnoses. Consequently, nearly half of these patients die.[2] In 2018, the WHO, together with St Jude Children's Research Hospital (St Jude) and the International Society of Pediatric Oncology, launched the Global Initiative for Childhood Cancer (GICC) with the aim to achieve at least a 60% global survival rate for children with cancer by 2030, and, together with the Pan American Health Organization (PAHO), Peru was designated as the first index country for the Region of the Americas.[3] The first steps to improve the care of Peruvian children with cancer were taken in 2016 when Peruvian experts in childhood cancer reviewed the rates of treatment abandonment and delayed diagnoses, and described the poor conditions of care for children with cancer nationwide.[2,4,5] Subsequently, in January 2017, Peruvian pediatric hematologists and oncologists jointly formed the national association for Hemato-Oncología Pediátrica del Peru (HOPPE) to improve conditions encountered by children with cancer through pediatric cancer training and research establishing a plan of action in the short and medium term. In June 2019, PAHO, St Jude, and the Ministry of Health of Peru convened the leading national stakeholders to launch the GICC in Lima. High-level authorities of the state ministries, social security of Peru (EsSalud), national hospitals, academic societies, international partners, and nonprofit organizations contributed to the GICC. Multidisciplinary GICC members formed 10 general working groups (ie, early diagnosis, abandonment, health services, professional education, registry, nursing, psychosocial, infection control, oncologic surgery, and palliative care) and three clinical groups (leukemia, retinoblastoma, and brain tumors, which are three of the six priority malignancies targeted by the WHO GICC to start with) assigned to develop clinical practice guidelines and strategic activities.[6] These working groups generated two official documents approved by the Ministry of Health that have become the cornerstone for childhood cancer care in Peru: the National Health Directive for Early Detection of Cancer in Children and Adolescents and the National Health Directive for the organization of pediatric hematology and oncology services (Fig 1).[7,8]
FIG 1

Milestones of the WHO Global Initiative for Childhood Cancer in Peru. HOPPE, Hemato-Oncología Pediátrica del Peru; GICC, Global Initiative for Childhood Cancer.

Milestones of the WHO Global Initiative for Childhood Cancer in Peru. HOPPE, Hemato-Oncología Pediátrica del Peru; GICC, Global Initiative for Childhood Cancer. Despite these advances, the COVID-19 pandemic has posed significant challenges to sustain the working groups and their activities, but it has also created an opportunity to develop legislation for childhood cancer services. During the COVID-19 pandemic, a survey published by the PAHO and Latin American Society for Pediatric Oncology described the experiences and opinions of childhood cancer specialists from cancer centers throughout Latin America, including Peru. The survey revealed that many services (30%-80%) such as radiotherapy and surgeries were suspended because of the pandemic. Moreover, potentially harmful chemotherapy modifications (35%) were implemented because of difficulties in acquiring medications.[9] Nevertheless, the pandemic increased the visibility of the disparity of childhood cancer deaths in Peru, leading the Peruvian legislature to propose the Childhood Cancer Law in April 2020. On September 2, 2020, President Martin Vizcarra and the Peruvian Parliament enacted the Childhood Cancer Law.[10] This represents an important step for the country, recognizing for the first time the importance of cancer in children as a public health priority in Peru. The Childhood Cancer Law has three primary objectives: (1) universal health coverage for early diagnoses and cancer-related treatments for all children and adolescents, (2) paid parental leave for caregivers of children and adolescents with cancer (a bonus equivalent of two minimum-wage salaries is to be granted to unemployed parents) while their child is hospitalized for treatment, and (3) creation of the National Program for Cancer in Children and Adolescents and a national pediatric cancer registry.[5] During the Childhood Cancer Law proposal process, a social movement called the Colectivo Cancer Infantil YA or Childhood Cancer Law NOW was born. This movement was championed chiefly by pediatric oncologists and parents of children with cancer. Among the achievements of the movement was the formation of a cohesive group of health professionals, volunteers, and parents (up to 150). This group harnessed the power of social networks, newspapers, television, radio, and other media to disseminate their message. PAHO has given its full support and provided advocacy for this purpose.[11] Finally, several stakeholders fully supported the Childhood Cancer Law through written and/or public statements. These stakeholders included the state ministries, EsSalud, physicians, politicians, foundations, and international partners (primarily St Jude and the Latin American Society for Pediatric Oncology). The estimated impact of the law is vast. It aims to save at least 650 lives per year, summing up to 169,000 healthy life years for children who receive successful treatment and survive to adulthood in Peru, and to prevent avoidable suffering among children and their families. Therefore, the Childhood Cancer Law will have great impact in the fight against childhood cancer in Peru, despite a global pandemic. This childhood cancer law is an example of successful collaboration of different stakeholders and can serve as a model for other countries as they become part of the GICC.
  5 in total

1.  Factors associated with the latency to diagnosis of childhood cancer in Peru.

Authors:  Liliana Vasquez; Monica Oscanoa; Mariela Tello; Elena Tapia; Ivan Maza; Jenny Geronimo
Journal:  Pediatr Blood Cancer       Date:  2016-07-09       Impact factor: 3.167

2.  Prognostic impact of diagnostic and treatment delays in children with osteosarcoma.

Authors:  Liliana Vasquez; Jose Silva; Sharon Chavez; Arturo Zapata; Rosdali Diaz; Fanny Tarrillo; Ivan Maza; Luis Sialer; Juan García
Journal:  Pediatr Blood Cancer       Date:  2020-01-11       Impact factor: 3.167

3.  Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru.

Authors:  Liliana Vasquez; Rosdali Diaz; Sharon Chavez; Fanny Tarrillo; Ivan Maza; Eddy Hernandez; Monica Oscanoa; Juan García; Jenny Geronimo; Nuria Rossell
Journal:  Pediatr Blood Cancer       Date:  2018-02-12       Impact factor: 3.167

4.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

5.  Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America.

Authors:  Liliana Vasquez; Claudia Sampor; Gabriela Villanueva; Essy Maradiegue; Mercedes Garcia-Lombardi; Wendy Gomez-García; Florencia Moreno; Rosdali Diaz; Andrea M Cappellano; Carlos Andres Portilla; Beatriz Salas; Evelinda Nava; Silvia Brizuela; Soledad Jimenez; Ximena Espinoza; Pascale Yola Gassant; Karina Quintero; Soad Fuentes-Alabi; Thelma Velasquez; Ligia Fu; Yessika Gamboa; Juan Quintana; Mariela Castiglioni; Cesar Nuñez; Arturo Moreno; Sandra Luna-Fineman; Silvana Luciani; Guillermo Chantada
Journal:  Lancet Oncol       Date:  2020-05-18       Impact factor: 41.316

  5 in total
  1 in total

1.  Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study.

Authors: 
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.